Combination Product: Conventional third-line therapy
ISL2024314
Unknown other active
Quick answer
Combination Product: Conventional third-line therapy for Colorectal Cancer (CRC) is a Unknown program (other) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Colorectal Cancer (CRC)
- Phase
- Unknown
- Modality
- other
- Status
- active